Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sami-Sabinsa Group is a research-driven health science company and a leading producer of standardized herbal extracts, phytonutrients, and specialty chemicals for the global market. Founded by Dr. Muhammed Majeed, the company integrates R&D, manufacturing, and marketing through its various divisions, including the marketing arm Sabinsa Corporation. The company's extensive portfolio features clinically studied branded ingredients such as Curcumin C3 Complex, BioPerine, and ForsLean, which are widely used in dietary supplements and cosmeceuticals. With over 400 patents granted worldwide, Sami-Sabinsa Group emphasizes evidence-based natural products and maintains state-of-the-art manufacturing facilities that adhere to international quality standards. The organization operates globally with a significant presence in India, the United States, Europe, and the Asia-Pacific region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sami Nutraceuticals.